These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 30367904)

  • 1. Estimating the population health impact of introducing a reduced-risk tobacco product into Japan. The effect of differing assumptions, and some comparisons with the U.S.
    Lee PN; Djurdjevic S; Weitkunat R; Baker G
    Regul Toxicol Pharmacol; 2018 Dec; 100():92-104. PubMed ID: 30367904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimating the effect of differing assumptions on the population health impact of introducing a Reduced Risk Tobacco Product in the USA.
    Lee PN; Fry JS; Hamling JF; Sponsiello-Wang Z; Baker G; Weitkunat R
    Regul Toxicol Pharmacol; 2017 Aug; 88():192-213. PubMed ID: 28651854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling the impact of changes in tobacco use on individual disease risks.
    Djurdjevic S; Sponsiello-Wang Z; Lee PN; Fry JS; Weitkunat R; Lüdicke F; Baker G
    Regul Toxicol Pharmacol; 2018 Aug; 97():88-97. PubMed ID: 29894733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ischemic Heart Disease and Chronic Obstructive Pulmonary Disease Hospitalizations in Japan Before and After the Introduction of a Heated Tobacco Product.
    van der Plas A; Antunes M; Romero-Kauss A; Hankins M; Heremans A
    Front Public Health; 2022; 10():909459. PubMed ID: 35836991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of risk of dying from tobacco-related diseases after quitting smoking in Italy.
    Carreras G; Pistelli F; Falcone F; Carrozzi L; Martini A; Viegi G; Gorini G
    Tumori; 2015; 101(6):657-63. PubMed ID: 26108248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel approach to assess the population health impact of introducing a Modified Risk Tobacco Product.
    Weitkunat R; Lee PN; Baker G; Sponsiello-Wang Z; González-Zuloeta Ladd AM; Lüdicke F
    Regul Toxicol Pharmacol; 2015 Jun; 72(1):87-93. PubMed ID: 25819932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating the public health impact had tobacco-free nicotine pouches been introduced into the US in 2000.
    Lee PN; Fry JS; Ljung T
    BMC Public Health; 2022 May; 22(1):1025. PubMed ID: 35597944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health Impact Assessment for Second-Hand Smoke Exposure in Germany--Quantifying Estimates for Ischaemic Heart Diseases, COPD, and Stroke.
    Fischer F; Kraemer A
    Int J Environ Res Public Health; 2016 Feb; 13(2):198. PubMed ID: 26861366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disease burdens from environmental tobacco smoke in Korean adults.
    Heo S; Lee JT
    Int J Environ Health Res; 2015; 25(3):330-48. PubMed ID: 25155457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using risk analysis in Health Impact Assessment: the impact of different relative risks for men and women in different socio-economic groups.
    Nilunger L; Diderichsen F; Burström B; Ostlin P
    Health Policy; 2004 Feb; 67(2):215-24. PubMed ID: 14720639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in smoking behavior and subsequent mortality risk during a 35-year follow-up of a cohort in Xi'an, China.
    He Y; Jiang B; Li LS; Li LS; Sun DL; Wu L; Liu M; He SF; Liang BQ; Hu FB; Lam TH
    Am J Epidemiol; 2014 May; 179(9):1060-70. PubMed ID: 24674900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tobacco Smoking Status and the Contribution to Burden of Diseases in Iran, 1990-2010: findings from the Global Burden of Disease Study 2010.
    Ghasemian A; Rezaei N; Saeedi Moghaddam S; Mansouri A; Parsaeian M; Delavari A; Jamshidi HR; Sharifi F; Naderimagham S
    Arch Iran Med; 2015 Aug; 18(8):493-501. PubMed ID: 26265517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CDC National Health Report: leading causes of morbidity and mortality and associated behavioral risk and protective factors--United States, 2005-2013.
    Johnson NB; Hayes LD; Brown K; Hoo EC; Ethier KA;
    MMWR Suppl; 2014 Oct; 63(4):3-27. PubMed ID: 25356673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pilot study: tobacco-attributable direct costs in two hospitals in Santiago, Chile].
    Martínez-Gutiérrez MS; Vanegas L J; Reveco U S; Valenzuela R R; Arteaga H O
    Rev Med Chil; 2008 Oct; 136(10):1281-7. PubMed ID: 19194624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Declining mortality from smoking in the United States.
    Rodu B; Cole P
    Nicotine Tob Res; 2007 Jul; 9(7):781-4. PubMed ID: 17577808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Smoking-attributable deaths in Spain in 1998].
    Banegas Banegas JR; Díez Gañán L; Rodríguez-Artalejo F; González Enríquez J; Graciani Pérez-Regadera A; Villar Alvarez F
    Med Clin (Barc); 2001 Dec; 117(18):692-4. PubMed ID: 11730631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling the Population Health Impact of Introducing a Modified Risk Tobacco Product into the U.S. Market.
    Djurdjevic S; Lee PN; Weitkunat R; Sponsiello-Wang Z; Lüdicke F; Baker G
    Healthcare (Basel); 2018 May; 6(2):. PubMed ID: 29772688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utilization of smoking-cessation pharmacotherapy among chronic obstructive pulmonary disease (COPD) and lung cancer patients.
    Vaidya V; Hufstader-Gabriel M; Gangan N; Shah S; Bechtol R
    Curr Med Res Opin; 2014 Jun; 30(6):1043-50. PubMed ID: 24432816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of Major Comorbidities in Chronic Obstructive Pulmonary Disease Caused by Biomass Smoke or Tobacco.
    Golpe R; Martín-Robles I; Sanjuán-López P; Cano-Jiménez E; Castro-Añon O; Mengual-Macenlle N; Pérez-de-Llano L
    Respiration; 2017; 94(1):38-44. PubMed ID: 28456807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. German EstSmoke: estimating adult smoking-related costs and consequences of smoking cessation for Germany.
    Sonntag D; Gilbody S; Winkler V; Ali S
    Addiction; 2018 Jan; 113(1):125-136. PubMed ID: 28734126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.